Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy

被引：2
|
作者：
Nishiyama-Fujita, Yuriko [1 ]
Nakazato, Tomonori [1 ]
Ito, Chisako [1 ]
Ogura, Shinji [1 ]
Mizuno, Kota [1 ]
Kamiya, Takahiro [1 ]
Aisa, Yoshinobu [1 ]
Mori, Takehiko [2 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Yokohama, Kanagawa, Japan
[2] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
来源：
INTERNAL MEDICINE JOURNAL | 2019年 / 49卷 / 09期
关键词：
D O I：
10.1111/imj.14432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1187 / 1189
页数：3
相关论文
共 50 条
  • [31] Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
    Sun, Kai
    Kasparian, Saro
    Iyer, Swaminathan
    Pingali, Sai Ravi
    ECANCERMEDICALSCIENCE, 2018, 12
  • [32] Overcoming Mantle Cell Lymphoma's Ibrutinib Resistance
    Sinha, Gunjan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
  • [33] Mantle Cell Lymphoma of the Ocular Adnexa
    Urdapilleta, Roxana Saucedo
    Rodriguez-Reyes, Abelardo A.
    Rodriguez-Martinez, Hector A.
    Lome-Maldonado, Carmen
    Hernandez-Ayuso, Ivette
    Gulias-Canizo, Rosario
    Rios y Valles-Valles, Dolores
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [34] MANTLE CELL LYMPHOMA OF THE OCULAR ADNEXA
    English, James
    Campbell, Thomas
    Sullivan, Timothy
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 103 - 103
  • [35] Can we improve on ibrutinib in mantle cell lymphoma?
    Rule, Simon
    LANCET HAEMATOLOGY, 2018, 5 (03): : E98 - E99
  • [36] Ibrutinib-associated Serositis in Mantle Cell Lymphoma
    Styskel, Brett A.
    Lopez-Mattei, Juan
    Jimenez, Carlos A.
    Stewart, John
    Hagemeister, Fredrick B.
    Faiz, Saadia A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : E43 - E44
  • [37] Overcoming primary ibrutinib resistance in mantle cell lymphoma
    Zhang, Leo
    Lan Pham
    Zhang, Hui
    Xie, Jingmeng
    Tao, Wenjing
    Bell, Taylor
    Chen, Zhihong
    Nomie, Krystle
    Fang, Bingliang
    Wang, Michael
    CANCER RESEARCH, 2016, 76
  • [38] Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials
    Vorobyev, Vladimir I.
    Zherebtsova, Vera A.
    Dubrovin, Egor I.
    Bychenkova, Liudmila A.
    Butaev, Lev S.
    Muha, Larisa A.
    Kochkareva, Yulia B.
    Ivanova, Valentina L.
    Nikitin, Eugene A.
    Tumyan, Gayane
    Doronin, Vadim A.
    Krijanovski, Oleg I.
    Ptushkin, Vadim
    BLOOD, 2019, 134
  • [39] Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study
    Zhang, Yuchen
    Liu, Panpan
    Cai, Jun
    Jing, Hongmei
    Zou, Liqun
    Huang, Huiqiang
    Wu, Yuanbin
    Li, Wenyu
    Zhong, Liye
    Jin, Xueli
    Ye, Xu
    Feng, Ru
    Zhang, Huilai
    Zhang, Liling
    Lin, Lie
    Sun, Xiuhua
    Tian, Yuyang
    Xia, Zhongjun
    Li, Zhiming
    Huang, He
    Xia, Yi
    Cai, Qingqing
    CANCER MEDICINE, 2022, 11 (22): : 4134 - 4145
  • [40] CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
    Viktoria Fuhr
    Shanice Heidenreich
    Mugdha Srivastava
    Angela Riedel
    Johannes Düll
    Elena Gerhard-Hartmann
    Andreas Rosenwald
    Hilka Rauert-Wunderlich
    Cell Death Discovery, 8
12345